搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
4 天
on MSN
I’m a doctor — female nonsmokers get lung cancer more than men, look out for these ...
"The odds of beating lung cancer are increasingly good as time goes on," said Dr. Daniel Sterman, the division director for ...
emjreviews.com
1 天
Evolving Patient Centered Therapies for Metastatic NSCLC
The metastatic non-small cell lung cancer (mNSCLC) treatment landscape has vastly expanded over the past two decades as a ...
10 小时
Susan Wojcicki’s last letter: Former YouTube CEO's final words on fighting lung cancer ...
YouTube released a letter from former CEO Susan Wojcicki, revealing her struggle with lung cancer before her death at 56.
Opinion
News Day
16 小时
Opinion
Stop smoking to minimise likelihood of lung cancer
There is no sure way to prevent lung cancer but you can reduce the risk of it by not smoking. You can reduce your children’s ...
The American Journal of Managed Care
11 小时
Elacestrant Shows Significant PFS Benefit in ESR1-Mutated Metastatic Breast Cancer
Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...
News Medical
11 小时
Targeted therapy induces regression in colorectal liver metastases
Explore how E-selectin-targeted polymer-doxorubicin therapy induces regression in colorectal liver metastases.
Cure Today
11 天
COVID-19 RNA May Be Linked to Metastatic Cancer Regression
RNA from the COVID-19 infection in patients with certain metastatic cancers may be associated with tumor shrinkage, but more ...
Opinion
The Register-Herald
7 小时
Opinion
Lung cancer in West Virginia: Preserving the advance premium tax credits is crucial
November is Lung Cancer Awareness Month — coinciding with the start of open enrollment for Affordable Care Act (ACA) ...
BioPharma Dive
3 天
Roche’s TIGIT-targeting drug for cancer fails its biggest test
Long-awaited results released Tuesday showed adding tiragolumab to Roche's immunotherapy Tecentriq did not extend survival in ...
Seeking Alpha on MSN
3 天
Roche anti-TIGIT therapy fails to extend survival in late-stage lung cancer trial
In 2022, the Swiss pharma giant said SKYSCRAPER-01 failed to reach the co-primary goal of progression-free survival. The ...
生物通
3 天
我国学者在肺癌脑转移靶向治疗耐药研究方面取得进展
在国家自然科学基金项目(批准号:82072784、82072785、82273304、82303437)等资助下,复旦大学附属华山医院毛颖教授、花玮教授和迟喻丹研究员团队在免疫逃逸参与肺癌脑转移靶向治疗耐药研究方面取得进展。研究成果以“通过CTLA4 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈